From testing state-of-the-art immunotherapies, to finding ways to help people recover more quickly after a stem cell transplant, our researchers are working hard to find more effective and kinder treatments for lymphoma. Below are some examples of what our researchers are doing right now.
Dr Kate Cwynarski is running one of the first clinical trials to investigate how we should treat people with diffuse large B cell lymphoma (DLBCL), a type of cancer that starts in the white blood cells, when it spreads to the brain or spine. This trial could lead to safer and more effective ways to treat people with this cancer.
Professor Andrew Pettitt in Liverpool is leading several clinical trials in follicular lymphoma, the most common form of low-grade non-Hodgkin lymphoma. He’s aiming to find the best combination of treatment for older people with the disease. He’s also testing if a new scan that measures the activity of tumours can help doctors decide how much treatment patients need.
Read more about one of Professor Pettitt's trials
Dr Mark Bishton is co-leading a trial called REFRACT to accelerate the development of new therapies for follicular lymphoma, a common subtype of non-Hodgkin lymphoma. The results from the trial will be used to identify promising new treatments, inform future trials and create a platform for the comparison of the efficacy of new therapies ongoing.
Search our database of clinical trials
Thanks to research, we've helped change the outlook for people with lymphoma.
Meet people like Rajvinder who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.
Want to find more information about our research or lymphoma?
